Journals / Eurasian Journal of Medicine / 2017 / Cilt: 49 - Sayı: 1

The End of a Long Debate: Methylenetetrahydrofolate Reductase Gene Polymorphisms do not Increase Thrombosis Risk

Eski Bir Tartışmanın Sonu: Metilentetrahidrofolat Redüktaz Gen Polimorfizmleri Tromboz Riskini Artırmamaktadır

Pages
76–77
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
🔖

Cite This Article

OZCAN, M., SAHİN, U. (2022). The End of a Long Debate: Methylenetetrahydrofolate Reductase Gene Polymorphisms do not Increase Thrombosis Risk. Eurasian Journal of Medicine, Cilt: 49 - Sayı: 1, 76–77. https://ajindex.com/articles/509005

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (4)

  1. Ozturk N, Bakan E, Gul MA, Bakan N, Sebin E, Kiziltunc A. the frequency of some thrombophilic mutations in eastern Turkey. Eurasian J Med 2016
  2. [CrossRef] 2. Simone B, De Stefano V, Leoncini E, et al. Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls. Eur J Epidemiol 2013
  3. [CrossRef] 3. Karki R, Pandya D, Elston RC, Ferlini C. Defining “mutation” and “polymorphism” in the era of personal genomics. BMC Med Genomics 2015
  4. [CrossRef] 4. International Committee of Medical Journal Editors. Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals: 2015 [updated December 2015]. Available at: URL: http://www.icmje.org